Project
Offene, nicht kontrollierte, multizentrische Phase IIIb Studie zur Beurteilung von Riociguat (BAY 63-2521) bei Patienten mit Chronisch Thromboembolischer Pulmonaler Hypertonie (CTEPH)
Aborted ยท 2013 until 2015
Brutsche Martin, Pellet Sarah, Finger Rebekka
Type
Range
Units
Status
Start Date
End Date
Financing
Study Design
Brief description/objective
Objective
1) To assess safety and tolerability, clinical effects of riociguat.
2) To provide access to riociguat for patients with in-operable chronic
thromboembolic pulmonary hypertension (CTEPH), or recurrent or persisting pulmonary hypertension (PH) after surgical treatment who are not satisfactorily treated an d cannot participate in any other CTEPH trial.